News

Dana Boucher found relief with LUTATHERA, a targeted radioactive therapy specifically for neuroendocrine tumors (NETs) found in the gut or pancreas.

Born with congenital heart disease, 41-year-old Christin Murphy has undergone three heart surgeries to repair pulmonary valves. They have been tough to get through, but Murphy says this latest one at Saint Luke’s changed her outlook.

When Debbie O’Neal was diagnosed with heart failure at 75, she feared her life was ending. She was the same age that her mother had been when she died of heart disease.

For people age 60 or older, or who have a family history of heart disease, one simple test and a matter of minutes can determine the potential risk of a future heart attack.

Dr. Adnan Chhatriwalla, interventional cardiologist at Saint Luke’s Mid America Heart Institute, talks about symptoms of heart valve disease, treatment, and keys to long-term heart health.

The Wall Street Journal invited Dr. James O’Keefe, MD, director of preventive cardiology at Saint Luke’s Mid America Heart Institute, to explain the potential risk and share tips on how you can protect your heart during the big game.

Dr. Tracy Stevens and Dr. Anna Grodzinsky joined the America's Healthcare Advocate podcast to talk about heart conditions in women.

TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.

Rehospitalization after aortic valve replacement (AVR) is associated with an increased risk of patient mortality, according to new research.

Caring for the patient at Saint Luke’s Hospital extended to saving the life of a spouse during a Louisiana couple’s fateful trip to Kansas City